ABSTRACT: A process for manufacturing virally-safe porcine bone hydroxyapatite (HA) has been developed to serve as advanced xenograft material for dental applications. Porcine bone pieces were defatted with successive treatments of 30% hydrogen peroxide and 80% ethyl alcohol. The defatted porcine bone pieces were heat-treated in an oxygen atmosphere box furnace at 1,300°C to remove collagen and organic compounds. The bone pieces were ground with a grinder and then the bone powder was sterilized by gamma irradiation. Morphological characteristics such as SEM (Scanning Electron Microscopy) and TEM (Transmission Electron Microscopy) images of the resulting porcine bone HA (THE Graft ® ) were similar to those of a commercial bovine bone HA (Bio-Oss ® ). In order to evaluate the efficacy of 1,300°C heat treatment and gamma irradiation at a dose of 25 kGy for the inactivation of porcine viruses during the manufacture of porcine bone HA, a variety of experimental porcine viruses including transmissible gastroenteritis virus (TGEV), pseudorabies virus (PRV), porcine rotavirus (PRoV), and porcine parvovirus (PPV) were chosen. TGEV, PRV, PRoV, and PPV were completely inactivated to undetectable levels during the 1,300ºC heat treatment. The mean log reduction factors achieved were ≧4.65 for TGEV, ≧5.81 for PRV, ≧6.28 for PRoV, and ≧5.21 for PPV. Gamma irradiation was also very effective at inactivating the viruses. TGEV, PRV, PRoV, and PPV were completely inactivated to undetectable levels during the gamma irradiation. The mean log reduction factors achieved were ≧4.65 for TGEV, ≧5.87 for PRV, ≧6.05 for PRoV, and ≧4.89 for PPV. The cumulative log reduction factors achieved using the two different virus inactivation processes were ≧9.30 for TGEV, ≧11.68 for PRV, ≧12.33 for PRoV, and ≧10.10 for PPV. These results indicate that the manufacturing process for porcine bone HA from porcine-bone material has sufficient virus-reducing capacity to achieve a high margin of virus safety.
. Xenografts are obtained from the bones of individuals of other species with composition and biomechanical properties that are almost similar to human bone. Two illustrations of xenografts used in dentistry are i) coral-derived bone substitutes with geometry similar to that of human cancellous bone interconnected macropores (200-600 µm) and ii) demineralized animal bone grafts, which are biocompatible and osteoconductive (Jensen et al., 2009) . Synthetic bone graft substitute materials are osteoconductive alloplastic materials such as calcium phosphate and bioactive glass (Välimäki and Aro, 2006) .
The use of xenografts has increased in recent years because adequate amounts can be easily obtained. However, they also have a limitation as the risk of transmission of zoonotic diseases is possible. The best known demineralized xenograft is bovine bone mineral (Bio-Oss ® ), which has a porous structure similar to human osseous tissue as well as a long resorption time, serving as an ideal scaffold for osteogenesis (Pinholt et al., 1991; Haas et al., 1998) . It is consisted of HA prepared by alkaline treatment and thermal treatment at 300°C to remove organic components of medullar bovine bone. Another bovine xenograft is Gen-Ox ® obtained through deproteinization at high temperatures (between 950 and 1,000°C) (Accorsi-Mendonça et al., 2008) . However, a unique safety issue with using bovine materials, namely the risk of bovine spongiform encephalopathy (BSE) transmission, is rarely addressed in literature and appears to be ignored by practitioners. BSE is a type of transmissible spongiform encephalopathy (TSE) or prion disease, which is a group of fatal neurodegenerative diseases affecting humans and a broad spectrum of animal species (Kim et al., 2016) . Therefore, porcine bone is considered an alternative to bovine bone.
Purgo Corp. in Korea is currently producing a dental xenograft material (THE Graft ® ) from porcine bones. THE Graft ® is a resorbable bone substitute material that consists of HA. It is prepared by removing organic compounds from porcine bone pieces using 30% hydrogen peroxide and 80%
ethyl alcohol solutions for 12 h each. After rinsing with distilled water, bone pieces are dried at 100°C for 24 h and heat-treated in an oxygen atmosphere box furnace at 1,300°C
to remove collagen and organic compounds. The bone pieces are ground with a grinder. Finally, gamma irradiation is performed (Kim et al., 2014a (Kim et al., , 2014b .
The medical grafting products, developed from porcine tissues, also have a risk of viral contamination (Hodde and Hiles, 2002) . Therefore, the ability to remove and/or to inactivate viral contaminants during the manufacturing of animal-derived bone material has become an important parameter for assessing the safety of the products (Forest et al., 2007; International Organization for Standardization, 2007; Bae et al., 2010 Bae et al., , 2012 . The manufacturing process for THE Graft ® contains an intentional viral inactivation procedure through gamma irradiation. Also it involves a 1,300°C heat treatment procedure which can potentially inactivate viral contaminants.
In this study, we have developed a manufacturing process for a virally-safe dental graft material from porcine bone and 미생물학회지 제52권 제2호 
Materials and Methods
Manufacturing process for porcine bone HA Pore size analysis was performed on SEM images taken at various magnifications. Pore size was defined as the longest distance across a single pore. An aliquot from each sample used in the virus inactivation studies and an appropriate control were titrated immediately after being collected in 7-fold serial dilutions to the end point using a quantal 50% tissue culture infectious dose (TCID50) assay (Kärber, 1931) . For titration of the viruses, indicator cell monolayers in 24-well culture plates were infected using at least eight replicates of 0.25 ml of the appropriate dilution of each sample or the positive control. Negative control wells were mock-infected using at least eight replicates of 0.25 ml of the culture medium. The plates were then incubated at 35°C for Virus inactivation during the manufacture of dental xenograft material • 143 approximately 1 h, and the wells were fed with 1 ml of the tissue culture medium. After 7-14 days incubation, the wells were examined for cytopathic effect (CPE).
Preparation and titration of viruses
As a part of the virus validation protocol, cytotoxicity, interference and load titer tests were performed. The cytotoxicity tests were performed on those samples generated for virus titration in virus spiking experiments to control for any possible cytotoxic effects on the indicator cells that might interfere with the virus titration. The interference tests were performed to determine whether the starting materials for virus spiking studies exerted an inhibitory effect on the ability of the cell lines to permit the detection of the virus. The load titer assays were performed to determine precisely the point at which spiking level leads to a loss in the virus titer.
Virus inactivation studies
Virus inactivation studies were conducted using the vali- 
Calculation of virus reduction factors
The virus log reduction factor was defined as the log10 of the 
Results

Morphological characterization of porcine bone HA
The morphological characteristics of porcine bone HA (THE Graft ® ) prepared from this study were compared with those of a commercial bovine bone HA (Bio-Oss ® ). SEM was used for the surface structure observation. Figure 2 shows the macro-porous nature of the two graft materials and similar structures. Also, the TEM images were very similar for Bio-Oss ® and THE Graft ® (Fig. 3) . The TEM image clearly showed the micro-porous nature of the two graft materials and similar structures. The major pore size distributions of THE Graft ® and Bio-Oss ® are similar. They are evenly distributed from 0.03 mm to 1.0 mm (Fig. 4) . 
Virus inactivation by heat treatment
Heat treatment at 1,300°C was extremely effective at inactivating all the viruses tested ( Table 2 ). All the viruses were completely inactivated to undetectable levels within 30 min of heat treatment. The log reduction factors achieved were ≥4.81
for TGEV, ≥4.49 for PRV, ≥6.28 for PRoV, and ≥5.21 for PPV.
Virus inactivation by gamma irradiation
Gamma irradiation was also very efficient at inactivating all the viruses tested (Table 3) . TGEV was rapidly inactivated from an initial titer of 6.35 log10 TCID50 to 2.07 log10 TCID50 after 5 kGy irradiation and then to undetectable levels after 15 kGy irradiation. PRV was completely inactivated from an initial titer of 7.57 log10 TCID50 to undetectable levels after 5 kGy irradiation. PRoV was also rapidly inactivated from an initial titer of 7.77 log10 TCID50 to 2.42 log10 TCID50 after 5 kGy irradiation and then to undetectable levels after 15 kGy
Virus inactivation during the manufacture of dental xenograft material • 145 b These values were calculated using a theoretical minimum detectable level of infectious virus with a 95% confidence level.
irradiation. PPV was rapidly inactivated from an initial titer of 6.59 log10 TCID50 to 2.167 log10 TCID50 after 5 kGy irradiation and then to undetectable levels after 15 kGy irradiation. The log reduction factors achieved were ≥4.65 for TGEV, ≥5.87 for PRV, ≥6.05 for PRoV, and ≥4.88 for PPV.
Discussion
Surface reactivity is one of the common characteristics of bone bioactive materials. It contributes to their bone bonding ability and their enhancing effect on bone tissue formation.
Especially, the surface structure, particle size, and size range are very important, as they directly affect the surface area available to react with cells and biological fluid (Ducheyne and Qiu, 1999) . Bio-Oss ® , bovine bone HA, is prepared from cow bones by heating them at relatively low temperature (300°C) to remove organic substances using alkaline chemicals and by sterilization with dry heat (Concannon et al., 1997) . It is known as an ideal scaffold for osteogenesis because it has a porous structure similar to human osseous tissue (Pinholt et al., 1991; Haas et al., 1998) . Therefore, the surface structure and pore size of porcine bone HA (THE Graft (Figs. 2, 3 , and 4). In the comparative animal efficacy studies of THE Graft ® and Bio-Oss ® using rat calvarial defects and rabbit calvarial defects models, there were no differences between the bones formed by the two graft materials (Yoo et al., 2010; Park et al., 2012) . Therefore 
